Cell Culture and Fermentation Sciences, MedImmune, Gaithersburg, MD, United States.
Cell Culture and Fermentation Sciences, MedImmune, Gaithersburg, MD, United States.
J Immunol Methods. 2019 Jan;464:31-39. doi: 10.1016/j.jim.2018.10.007. Epub 2018 Oct 17.
Development of cell lines for biotherapeutic protein production requires screening large numbers of clones to identify and isolate high producing ones. As such, stable cell line generation is a time- and resource-intensive process. There is an increasing need to enhance the selection efficiency of high-yielding clonal cell lines for cell line development projects by using high throughput screening of live cells for markers predictive of productivity. Single cell deposition by fluorescence activated cell sorting (FACS) is a commonly performed method for cloning to generate cell lines derived from a single recombinant cell. We have developed a novel strategy to identify higher productivity cells at the FACS step by leveraging a simple viable cell staining method that detects mitochondrial membrane potential (Ψm), a key indicator of cellular metabolic activity. We chose a dual-emission dye (Mito-ID, Enzo Life Sciences) that fluoresces green and orange in living cells with the intensity of the orange fluorescence being dependent on the cells Ψm status. Using available clonal cell lines with known productivity, or stable transfectant pools, we evaluated Ψm of cell populations with Mito-ID dye. We determined that the intensity of the Ψm fluorescent signal correlates with the known fed-batch titers of the producer clones, and that cell sorting based on an optimal Ψm staining intensity selectively enriches for higher producing clones from nonclonal transfectant pools. These clones are phenotypically stable for recombinant protein production. Furthermore, the strategy has been successfully applied to identifying higher producing cell lines for a range of antibody molecular formats. Using this method, we can combine an enriching step with the cloning step for high producers, thereby saving time and resources in cell line development.
为了生产生物治疗蛋白,需要筛选大量的克隆细胞来鉴定和分离高产细胞。因此,稳定细胞系的建立是一个既耗时又耗资源的过程。越来越需要通过高通量筛选活细胞中的生产力预测标记物来提高细胞系开发项目中高产克隆细胞系的选择效率。通过荧光激活细胞分选(FACS)进行单细胞沉积是一种常用的克隆方法,用于从单个重组细胞生成细胞系。我们开发了一种新策略,通过利用一种简单的活细胞染色方法来鉴定 FACS 步骤中的高生产力细胞,该方法检测线粒体膜电位(Ψm),Ψm 是细胞代谢活性的关键指标。我们选择了一种双发射染料(Mito-ID,Enzo Life Sciences),在活细胞中发绿色和橙色荧光,橙色荧光的强度取决于细胞的Ψm 状态。使用具有已知生产力的可用克隆细胞系或稳定转染体池,我们用 Mito-ID 染料评估细胞群体的Ψm。我们确定,Ψm 荧光信号的强度与生产克隆的已知分批补料批得率相关,并且基于最佳Ψm 染色强度的细胞分选选择性地从非克隆转染体池中富集高产克隆。这些克隆在重组蛋白生产方面具有表型稳定性。此外,该策略已成功应用于鉴定一系列抗体分子形式的高产细胞系。使用这种方法,我们可以将富集步骤与高产细胞的克隆步骤结合起来,从而在细胞系开发中节省时间和资源。